Pharmacy Industry Updates: October
Every month, our Industry Relations Director, LeAnn Lewis provides an in-depth industry update to customers. Below, you will find the agenda for the industry update for October. If you have any questions regarding any of the points, contact us here.
- New Hampshire – New Data Submission Guide v2.2
- No longer allows Payment Type of “Other”
- Oklahoma – Effective 09-01-2019, Requires Treatment Type (DSP24)
- OK has committed to not generate errors on Treatment Type until 01-01-2020. Industry push back may delay that date even further.
- Nebraska – Effective 09-30-2019 – Possibly delayed another two weeks.
- Changing from DrFirst to a NIC’s RxGov Platform
- Nebraska changed the port from 177330 to 17730
- Requires ASAP 4.2A with new fields of Gender, Phone, and Patient ID
- New Data Submission Guide is available.
- Account Signup available as of 08-05-2019
- Alabama – Gabapentin Schedule V as of 11-18-2019
- Oregon – Effective likely 01-01-2020
- Require Gabapentin Reporting as a Drug of Concern
- Require Diagnosis Code and “reason for the prescription”
- California –Still waiting on new format of serial number and barcode required by 01-01-2020
- PDMP reporting – required now if serial number is on the form.
- Florida – ASAP V4.2A Accepted now, but required as of 12-19-2019
Potential PDMP Changes
- Utah – Will be moving to NIC’s RxGov in the future
- 09-10-2019 – Finalized in the next 30-45 days
Legislative/Regulatory Reminders for September 2019
- Arizona – Updated rules about what a pharmacist can modify on a controlled substance prescription.
- Oregon – Must post information about the availability of Naloxone.
- Update rules on emergency fills of a controlled substance
- No longer allows multiple prescriptions to be written on the same date
- Requires checking of PDMP data prior to dispensing most controlled substances
- Must provide notice of safe disposal of medication (BOP to develop documentation)
- Prohibited to sell Dextromethorphan to minors without a prescription
- Nebraska – Requires plans to cover medication synchronization with pro-rated co-pays and full dispensing fees.
New Legislative/Regulatory Highlights
- Pennsylvania – Electronic Prescribing of Controlled Substances
- Maryland – Strengthened PBM Legislation
- Connecticut – Updated PDMP Checking prior to dispensing and counseling rules
- Alabama – Updated Collaborative Practice Rules
Get Involved/Get Informed Spotlight
- Hazardous Drugs
- USP <800> In effect as o 12-01-2019
- USP <795>, <797>, <825> delayed until further notice
- EPA Management Standards for Hazardous Waste Pharmaceuticals
- Idaho – Cannot accept cash payment for opioids from a known Medicaid beneficiary
- Side Effects of the New York Opioid Tax
- Track and Trace (DSCSA)
- NCPDP SCRIPT V2017071 Reminder
Contact us to ask questions or get more information about these updates.
The organizer of this call is not an attorney, and the presentation on this call does not constitute legal advice. It contains only the opinions and observations of the organizer and its participants. Any use of information contained in this presentation is at the user’s own risk. The organizer will not be available for depositions or testimony in case of litigation.